Rausing laboratory of Lund - Tumor section
61 – 70 of 84
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Effect of Blockade of Indoleamine 2, 3-dioxygenase in Conjunction with Single Fraction Irradiation in Rat Glioma
(
- Contribution to journal › Article
-
Mark
A GFP Positive Glioblastoma Cell Line NS1 : A New Tool for Experimental Studies
(
- Contribution to journal › Article
- 2014
-
Mark
Simultaneous fMRI and EEG during the Multi-Source Interference Task
(
- Contribution to journal › Article
-
Mark
Glioma Cell Proliferation Controlled by ERK Activity-Dependent Surface Expression of PDGFRA.
(
- Contribution to journal › Article
-
Mark
On the variations of Cervical Dermatomes
(
- Contribution to journal › Article
-
Mark
A glioma classification scheme based on coexpression modules of EGFR and PDGFRA
2014) In Proceedings of the National Academy of Sciences of the United States of America 111(9). p.3538-3543(
- Contribution to journal › Article
- 2013
-
Mark
Zebularine induces long-term survival of pancreatic islet allotransplants in streptozotocin treated diabetic rats.
(
- Contribution to journal › Article
-
Mark
Better Prognosis of Patients with Glioma Expressing FGF2-Dependent PDGFRA Irrespective of Morphological Diagnosis.
(
- Contribution to journal › Article
- 2012
-
Mark
An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by combined treatment with zebularine and IFN-γ: Potential therapeutic use in autoimmune diseases.
(
- Contribution to journal › Article
-
Mark
Photon activation therapy of RG2 glioma carrying Fischer rats using stable thallium and monochromatic synchrotron radiation.
(
- Contribution to journal › Article